PDL BioPharma, Inc. (
) will begin trading ex-dividend on September 03, 2013. A cash
dividend payment of $0.15 per share is scheduled to be paid on
September 12, 2013. Shareholders who purchased PDLI stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This marks the 12th quarter that PDLI has paid the same dividend.
At the current stock price of $7.86, the dividend yield is
The previous trading day's last sale of PDLI was $7.86,
representing a -7.26% decrease from the 52 week high of $8.48 and a
20.92% increase over the 52 week low of $6.50.
PDLI is a part of the Health Care sector, which includes
companies such as Gilead Sciences, Inc. (
) and Amgen Inc. (
). PDLI's current earnings per share, an indicator of a company's
profitability, is $1.64. Zacks Investment Research reports PDLI's
forecasted earnings growth in 2013 as 18.54%, compared to an
industry average of 5.7%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to PDLI through an Exchange
Traded Fund [ETF]?
The following ETF(s) have PDLI as a top-10 holding:
- WisdomTree Trust SmallCap Dividend Fund (
- WisdomTree SmallCap Earnings Fund (
The top-performing ETF of this group is EES with an increase of
14.27% over the last 100 days. DES has the highest percent
weighting of PDLI at 0.88%.